News archive
283 results
-
Susanna Peltoniemi appointed Director of Fimea's Monitoring and Availability area of responsibility
-
EMA to organise training on transition for non-commercial sponsors 9.2.2024
-
Pharmacies are soon allowed to substitute a biological medicine with a more affordable alternative
-
Wider problems of shortages in 2023 concentrated on a few products
-
Extended validity of the Decree on fees chargeable by the Finnish Medicines Agency
-
The new decree on fees chargeable by the Finnish Medicines Agency into force on 1 January 2024
-
Possibility to access Finnish Institute for Health and Welfare register data in clinical trials from 1 January 2024 onwards
-
Publication of clinical trial documents during the transition period
-
Medical device operator: Check the registered information for the supervision fee to be collected in 2024
-
First version of EU list of critical medicines published
-
Online reporting of adverse drug reactions to be renewed
-
State of implementation of the MD and IVD regulations discussed at ministerial level
-
Important information on the transition of clinical trials to comply with the EU Regulation
-
Survey of medical device manufacturers to assess the impact of the new regulation
-
Fimea participates in an EU4Health project focusing on market surveillance of medical devices
-
Sales of antibiotics for production animals halved in Europe over ten years
-
Composition of Fimea’s patient advisory board for the term 2024–2025
-
Correct information is the key to successful medicinal treatment of the elderly
-
The European Medicines Agency recommends granting marketing authorisation to the updated Nuvaxovid vaccine
-
Fimea designates a new notified body under the IVD Regulation in Finland
Showing 21 - 40 / 283